Band Therapeutics Report issue

For profit Phase 1
Founded: Lexington MA United States (2013)
Status: Left NME R&D (2019)

Organization Overview

First Clinical Trial
2019
NCT04103034
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Band Therapeutics

Active Ingredients

Drugs in Phase 1 Trials (2)

bt200 (1 trial)

desmopressin (ddavp) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arteriosclerosis (Phase 1)

Atherosclerosis (Phase 1)

Intracranial Arteriosclerosis (Phase 1)

Stroke (Phase 1)

Thrombosis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 2